Dapsone-associated	dapsone-associated	O	O	O	O
Heinz	heinz	O	O	O	O
body	body	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
anemia	anemia	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
Cambodian	cambodian	O	O	O	O
woman	woman	O	O	O	O
with	with	O	O	O	O
hemoglobin	hemoglobin	CHEMICALS	O	OTHERS	I
E	e	CHEMICALS	O	OTHERS	I
trait	trait	O	O	O	O
.	.	O	O	O	O

A	a	O	O	O	O
Cambodian	cambodian	O	O	O	O
woman	woman	O	O	O	O
with	with	O	O	O	O
hemoglobin	hemoglobin	CHEMICALS	O	OTHERS	I
E	e	CHEMICALS	O	OTHERS	I
trait	trait	O	O	O	O
(	(	O	O	O	O
AE	ae	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
leprosy	leprosy	O	O	OTHERS	I
developed	developed	O	O	O	O
a	a	O	O	O	O
Heinz	heinz	O	O	O	O
body	body	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
anemia	anemia	O	DISEASE	OTHERS	I
while	while	O	O	O	O
taking	taking	O	O	O	O
a	a	O	O	O	O
dose	dose	O	O	O	O
of	of	O	O	O	O
dapsone	dapsone	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
50	50	O	O	O	O
mg/day	mg/day	O	O	O	O
)	)	O	O	O	O
not	not	O	O	O	O
usually	usually	O	O	O	O
associated	associated	O	O	O	O
with	with	O	O	O	O
clinical	clinical	O	O	O	O
hemolysis	hemolysis	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Her	her	O	O	O	O
red	red	O	O	O	O
blood	blood	O	O	O	O
cells	cells	O	O	O	O
(	(	O	O	O	O
RBCs	rbcs	O	O	O	O
)	)	O	O	O	O
had	had	O	O	O	O
increased	increased	O	O	O	O
incubated	incubated	O	O	O	O
Heinz	heinz	O	O	O	O
body	body	O	O	O	O
formation	formation	O	O	O	O
,	,	O	O	O	O
decreased	decreased	O	O	O	O
reduced	reduced	O	O	OTHERS	I
glutathione	glutathione	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
GSH	gsh	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
decreased	decreased	O	O	O	O
GSH	gsh	CHEMICALS	O	OTHERS	I
stability	stability	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
pentose	pentose	O	O	OTHERS	I
phosphate	phosphate	CHEMICALS	O	OTHERS	I
shunt	shunt	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
dapsone-exposed	dapsone-exposed	O	O	O	O
AE	ae	O	O	O	O
RBCs	rbcs	O	O	O	O
was	was	O	O	O	O
increased	increased	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
normal	normal	O	O	O	O
RBCs	rbcs	O	O	O	O
.	.	O	O	O	O

Although	although	O	O	O	O
the	the	O	O	O	O
AE	ae	O	O	O	O
RBCs	rbcs	O	O	O	O
from	from	O	O	O	O
an	an	O	O	O	O
individual	individual	O	O	O	O
not	not	O	O	O	O
taking	taking	O	O	O	O
dapsone	dapsone	CHEMICALS	O	OTHERS	I
had	had	O	O	O	O
increased	increased	O	O	O	O
incubated	incubated	O	O	O	O
Heinz	heinz	O	O	O	O
body	body	O	O	O	O
formation	formation	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
GSH	gsh	CHEMICALS	O	OTHERS	I
content	content	O	O	O	O
and	and	O	O	O	O
GSH	gsh	CHEMICALS	O	OTHERS	I
stability	stability	O	O	O	O
were	were	O	O	O	O
normal	normal	O	O	O	O
.	.	O	O	O	O

The	the	O	O	O	O
pentose	pentose	O	O	OTHERS	I
phosphate	phosphate	CHEMICALS	O	OTHERS	I
shunt	shunt	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
non-dapsone-exposed	non-dapsone-exposed	O	O	O	O
AE	ae	O	O	O	O
RBCs	rbcs	O	O	O	O
was	was	O	O	O	O
decreased	decreased	O	O	O	O
compared	compared	O	O	O	O
to	to	O	O	O	O
normal	normal	O	O	O	O
RBCs	rbcs	O	O	O	O
.	.	O	O	O	O

Thus	thus	O	O	O	O
,	,	O	O	O	O
AE	ae	O	O	O	O
RBCs	rbcs	O	O	O	O
appear	appear	O	O	O	O
to	to	O	O	O	O
have	have	O	O	O	O
an	an	O	O	O	O
increased	increased	O	O	O	O
sensitivity	sensitivity	O	O	O	O
to	to	O	O	O	O
oxidant	oxidant	O	O	O	O
stress	stress	O	O	O	O
both	both	O	O	O	O
in	in	O	O	O	O
vitro	vitro	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
vivo	vivo	O	O	O	O
,	,	O	O	O	O
since	since	O	O	O	O
dapsone	dapsone	CHEMICALS	O	OTHERS	I
does	does	O	O	O	O
not	not	O	O	O	O
cause	cause	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
anemia	anemia	O	DISEASE	OTHERS	I
at	at	O	O	O	O
this	this	O	O	O	O
dose	dose	O	O	O	O
in	in	O	O	O	O
hematologically	hematologically	O	O	O	O
normal	normal	O	O	O	O
individuals	individuals	O	O	O	O
.	.	O	O	O	O

Given	given	O	O	O	O
the	the	O	O	O	O
influx	influx	O	O	O	O
of	of	O	O	O	O
Southeast	southeast	O	O	O	O
Asians	asians	O	O	O	O
into	into	O	O	O	O
the	the	O	O	O	O
United	united	O	O	O	O
States	states	O	O	O	O
,	,	O	O	O	O
oxidant	oxidant	O	O	O	O
medications	medications	O	O	O	O
should	should	O	O	O	O
be	be	O	O	O	O
used	used	O	O	O	O
with	with	O	O	O	O
caution	caution	O	O	O	O
,	,	O	O	O	O
especially	especially	O	O	O	O
if	if	O	O	O	O
an	an	O	O	O	O
infection	infection	O	DISEASE	OTHERS	I
is	is	O	O	O	O
present	present	O	O	O	O
,	,	O	O	O	O
in	in	O	O	O	O
individuals	individuals	O	O	O	O
of	of	O	O	O	O
ethnic	ethnic	O	O	O	O
backgrounds	backgrounds	O	O	O	O
that	that	O	O	O	O
have	have	O	O	O	O
an	an	O	O	O	O
increased	increased	O	O	O	O
prevalence	prevalence	O	O	O	O
of	of	O	O	O	O
hemoglobin	hemoglobin	O	O	O	O
E.	e.	O	O	O	O

